CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the company will be presenting at ThinkEquity’s Mid Year Check-up on Healthcare Conference at 8:30 a.m. EDT on June 16, 2010, in New York City.
